Dr.Chlara Maes

Active

Private limited companyfounded 20205 yrs activeOrgelstraat 6, 3803 Sint-Truiden, BelgiumKBO/BCE: BE 0757.953.545

Dr.Chlara Maes has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €60k and a net result of €153k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 19% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Watch Print / PDF

Checked score

Score 2024

80 / 100

Excellent

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability100=

Solvency53▼-47

Growth58▲+6

Track record94

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €4.5k at 30 days acceptable

Liquidity tight (current ratio 1.25 against 27.58 in 2023; short-term debt: 62.2% and cash: 64.7% of total assets), and 72.3% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 86

Relative position

BE, all sectors

reference

Sector 86

lower

← fewer bankruptcies more bankruptcies →

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 19907 sector peers (2024).

NBB · sector comparison

Position among 19907 sector peers

Solvency

better than 19%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-07-2025, 30 days ahead of the deadline.

NBB · 4 filings

Deviation from the deadline

2025

not confirmed

2024

30 d early

2023

12 d early

2022

19 d early

2021

11 d early

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity

€60k▼ 81.3%

2023 · €319k

2021: €137k 2022: €207k 2023: €319k

2021 → 2024

Total assets

€215k▼ 40.0%

2023 · €359k

2021: €140k 2022: €211k 2023: €359k

2021 → 2024

Net result

€153k▲ 37.5%

2023 · €111k

2021: €132k 2022: €70k 2023: €111k

2021 → 2024

Working capital

€33k▼ 88.7%

2023 · €296k

2021: €137k 2022: €207k 2023: €296k

2021 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line2021202220232024Trend

Equity€137k-€207k▲ 51.5%€319k▲ 53.7%€60k▼ 81.3%

Operating result€170k-€89k▼ 47.8%€144k▲ 61.4%€200k▲ 39.3%

Net result€132k-€70k▼ 46.6%€111k▲ 58.0%€153k▲ 37.5%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

After the dip in 2022 the operating result has climbed two years in a row; 2024 is 39% above 2023 and is the highest result in the available series.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €215k

22.2%

77.8%

Fixed assets €48k▼ 7.7%

Current assets €167k▼ 45.5%

Equity and liabilities €215k

27.7%

72.3%

Equity €60k▼ 81.3%

Debt €155k▲ 287%

The debt ratio rises from 11.2% to 72.3%. Equity is lower and debt is higher.

Key figures and ratios

2024 value · change against 2023

EBITDA

€212k▲

2023 · €146k

Cash flow

€165k▲

2023 · €114k

Solvency

27.7%▼

2023 · 88.8%

Current ratio

1.25▼

2023 · 27.58

Quick ratio

1.25▼

2023 · 27.58

Debt / equity

2.61▲

2023 · 0.13

ROE

256.9%▲

2023 · 34.9%

ROA

71.2%▲

2023 · 31.0%

Interest coverage

180.84▼

2023 · 352.18

Debt

€155k▲

2023 · €40k

Debt ≤ 1 year

€134k▲

2023 · €11k

Debt > 1 year

€22k▼

2023 · €29k

Income taxes

€46k▲

2023 · €32k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Assets

Total assets20/58€359k€215k▼

Fixed assets21/28€52k€48k▼

Tangible fixed assets22/27€52k€48k▼

Furniture and vehicles24€52k€48k▼

Current assets29/58€307k€167k▼

Amounts receivable within one year40/41€23k€28k▲

Trade receivables40€20k€28k▲

Other amounts receivable41€3k-

Cash at bank and in hand54/58€284k€139k▼

Equity and liabilities

Total equity and liabilities10/49€359k€215k▼

Equity10/15€319k€60k▼

Contributions10/11€5k€5k=

Reserves13€314k€55k▼

Distributable reserves133€314k€55k▼

Amounts payable17/49€40k€155k▲

Amounts payable after more than one year17€29k€22k▼

Financial debts170/4€29k€22k▼

Amounts payable within one year42/48€11k€134k▲

Current portion of amounts payable after more than one year42€7k€7k▲

Trade debts44€3k€7k▲

Suppliers440/4€3k€7k▲

Taxes, remuneration and social security45-€291

Taxes450/3-€291

Other amounts payable47/48€1k€119k▲

Income statement Code20232024

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€12k▲

Other operating charges640/8€268€325▲

Gross operating margin9900€147k€213k▲

Operating profit (loss)9901€144k€200k▲

Financial charges65/66B€416€1k▲

Recurring financial charges65€416€1k▲

Profit (loss) for the period before taxes9903€143k€199k▲

Income taxes67/77€32k€46k▲

Profit (loss) for the period9904€111k€153k▲

Profit (loss) for the period to be appropriated9905€111k€153k▲

Appropriation of the result

Profit (loss) to be appropriated9906€111k€153k▲

Transfer from equity791/2-€294k

Transfer to equity691/2€111k€35k▼

To other reserves6921€111k€35k▼

Profit to be distributed694/7-€412k

Return on contributions (dividend)694-€412k

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 7Financial 3Filings 4

2025

01-07

NBB filing Annual accounts filed

fiscal year 2024 · micro schema

2024

31-12

Financial Highest result since 2021net €153k ▲37.5%

Operating result €200k, net result €153k, both a record.

19-07

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

2023

12-07

NBB filing Annual accounts filed

fiscal year 2022 · micro schema

2022

31-12

Financial Weakest financial yearnet €70k ▼46.6%

Net result drops to €70k, the lowest in the series; recovery starts the following year.

31-12

Financial Equity above €200kEq €207k ▲51.5%

2 profitable years in a row build equity to €207k.

20-07

NBB filing Annual accounts filed

fiscal year 2021 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Sint-Truiden · 1 establishment unit since 2020

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Orgelstraat 63803 Sint-Truiden

Ground area

1,872 m²

Building footprint

262 m²

Volume, LiDAR

1,715 m³

Parcel 71061B0154/00H000, Flanders · tallest building 11.3 m, ±2 floors. Linked by address, not a title deed.

1 establishment unit

Dr.Chlara Maes

Orgelstraat 6, 3803 Sint-TruidenSpecialist medical practice

since 20202.309.538.029

1 parcel

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
71061B0154/00H000	Flanders	1,872 m²	1 · 262 m²	11.3 m · 2 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Dokter Thijs Cools

BE 0700.610.709

Mol · Eq €60k

DOKTER JAN VANDEREYCKEN

BE 0750.501.569

Sint-Martens-Latem · Eq €60k

J.A. Voncken Neurologie

BE 0779.942.950

Heusden-Zolder · Eq €59k

Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 5,388 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded10-11-2020

Fiscal year end31-12

Activities, NACEBEL

86220Specialist medical practice

Sources

Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.